Molecular follow-up of patient UPN 251 relapsing after BMT and responding to DLI.

(A) White blood cell counts, lineage-specific chimerism, and MRD (p210^BCR-ABL and p190^BCR-ABL) are depicted. Numbers express the percentage of host-type hemopoiesis; cytogenetic relapse (C) and hematological relapse (H) are noted in the figure. (B) Schematic representation of CML kinetic at molecular level and clinical parameters.